Immunotherapy in Chemorefractory Lung Cancer – OncLive
OncLive |
Immunotherapy in Chemorefractory Lung Cancer
OncLive Benjamin P. Levy, MD: Off of a clinical trial, I would say that patients who have received chemotherapy and their tumors are growing should be considered as candidates for immunotherapy. Not all patients will be candidates for immunotherapy, but we do … |
